CYCLOBUTANE AND METHYLCYCLOBUTANE DERIVATIVES AS JANUS KINASE INHIBITORS
- 专利权人:
- 发明人:
- LI YUN LONG,RODGERS JAMES D
- 申请号：
- IN2125/KOLNP/2012
- 公开号：
- IN2012KN02125A
- 申请日:
- 2012.08.09
- 申请国别(地区):
- IN
- 年份:
- 2013
- 代理人:
- 摘要：
- The present invention relates to cyclobutane and methylcyclobutane derivatives, as well as their salts, compositions, and methods of use, which are Janus kinase (JAK) inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer and myeloproliferative disorders.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Cyclobutane and methylcyclobutane derivatives as Janus kinase inhibitors
- Derivatives of pyrazole compounds - 4 - il - heterociclil - carboxamide inhibitors of disorders mediated by kinase pim-1,Pim pim - 2 and - 3 Pharmaceutical； composition； method of treatment； and its use for the treatment of cancer, immune disorders, cardiovascular diseases, and Viral Infections, among others.
- 5-(1H-PYRAZOL-5-YL)THIAZOLE-BASED COMPOUNDS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE EYE
- INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY AND USE THEREOF TO TREAT OPHTHALMIC DISORDERS
- INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY AND USE THEREOF TO TREAT OPHTHALMIC DISORDERS
